Quanta Magazine

Drugs that target the neurotransmitter serotonin have long been prescribed to treat depression. Now the spotlight is turning to other aspects of brain chemistry. In this episode, the neuropharmacologist John Krystal shares findings that are overturning our understanding of depression.

Related Keywords

Vietnam ,Republic Of ,United States ,Madison Goldberg ,Thomas Lin ,Genevieve Sponsler ,Edwin Ochoa ,Jaki King ,John Rennie ,Matt Carlstrom ,Nona Griffin ,John Krystal ,Julian Lin ,George Aghajanian ,Jocelyn Gonzales ,Janna Levin ,Samuel Velasco ,Arleen Santana ,Bert Odom Reed ,Ronald Duman ,Steve Strogatz ,Kristina Armitage ,Peter Greenwood ,Caitlin Faulds ,Olivia Brock ,Merritt Jacob ,Simons Foundation ,Johnson ,Yale Center ,Mental Health Awareness Month ,World Health Organization ,Columbia Journalism School ,Yale Department Of Psychiatry ,Morgan Church ,Yale School Of Medicine ,Yale School ,Apple Podcasts ,Quanta Magazine ,Yale Department ,Clinical Investigation ,Freedom Biosciences ,Vietnam War ,Cornell Broadcast ,